Equine protozoal myeloencephalitis vaccine
AssigneeWyeth
InventorsRocky Barry Bigbie, Terry Kaleung Ng, Joseph Wilson Whalen, Jr.
Life of this patent
Estimating the term…
Abstract
The present invention provides an immunogenically active component comprising inactivated Sarcocystis neurona cells and/or inactivated Neospora hughesi cells; antigens derived therefrom; DNA derived therefrom; or a mixture; or in combination with other vaccine components; thereof. Further provided are vaccine compositions useful for preventing or ameliorating equine protozoal myeloencephalitis infection and disease and a method for the cell culture propagation of protozoan parasites.
Claims16
An isolated and purified Sarcocystis neurona strain designated SNg, having ATCC Accession No. PTA-2972 or a subculture thereof.
An immunogenically active component useful for preventing or ameliorating equine protozoal myoencephalitis disease which comprises merozoite antibody-inducing whole cells of a Sarcocystis neurona isolate designated SNg, having ATCC Accession No. PTA-2972 or a subculture thereof.
Dependencies are inferred from the claim text.